Anna Lisa T Ong-Lim (Anna Lisa Ong-Lim)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Extracorporeal Membrane Oxygenation

Clinical Practice

Coronavirus Disease

Top Venues

Expert review of vaccines

The Pediatric infectious disease journal

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jason E Lang, Christoph P Hornik, Carrie Elliott, Adam P Silverstein, Chi D Hornik, Amira Al-Uzri, Miroslava Bosheva, John S Bradley, Charissa Fay Corazon Borja-Tabora, David Di John, Ana Mendez Echevarria, Jessica E Ericson, David Friedel, Ferenc Gonczi, Marie Grace Dawn Isidro, Laura P James, Krisztina Kalocsai, Ioannis Koutroulis, Istvan Laki, Anna Lisa T Ong-Lim, Marta Nad, Gabor Simon, Salma Syed, Eva Szabo, Daniel K Benjamin, Michael Cohen-Wolkowiez, null null
Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia. The Pediatric infectious disease journal 41 (7) (2022)
Usa Thisyakorn, Josefina C Carlos, Tawee Chotpitayasunondh, Tran Minh Dien, Maria Liza A M Gonzales, Thi Lien Huong Nguyen, Zulkifli Ismail, Musa M Nordin, Anna Lisa T Ong-Lim, Terapong Tantawichien, Sangita D Terumalay, Thiem Dinh Vu, Otávio Cintra, Olakunle Oladehin
Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies. Human vaccines & immunotherapeutics (2022)
Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Sunate Chuenkitmongkol, D V Dung, Kao-Pin Hwang, Javier Ortiz Ibarra, Sasisopin Kiertiburanakul, Prasad S Kulkarni, Christopher Lee, Ping-Ing Lee, Rommel Crisenio Lobo, Alejandro Macias, Cao Huu Nghia, Anna Lisa T Ong-Lim, Alfonso Javier Rodriguez-Morales, Rosana Richtmann, Marco Aurélio Palazzi Safádi, Hindra Irawan Satari, Guy Thwaites
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic. Expert review of vaccines (2022)